INTRODUCTION
The serum level of the liver enzyme, gamma-glutamyl transferase (GGT), is age-dependent. The upper limit of normal values in the neonate is usually reported to be between five and eight times greater than for adults 1, 2 and declines to adult values over the first few months of life. A wide variation of reference ranges exists in the literature for both the fetus and the neonate. 3 -5 This variation may simply reflect variability in perinatal influences or may represent one or more unidentified confounding factors, such as maternal drug ingestion or unidentified perinatal liver disease.
Elevated serum GGT activity is used clinically as a marker of bile duct injury in both adults and children. In addition, GGT is an inducible enzyme, and numerous enzyme-inducing drugs, most notably warfarin, phenobarbital, and phenytoin, elevate the serum level of the enzyme when no evidence of hepatic disease is apparent. 6, 7 We have anecdotally observed a number of newborns with the isolated finding of greatly increased serum GGT. Further investigations in these babies have failed to reveal any evidence of liver disease or systemic disorder, but some infants were noted to be children of cocaine-abusing mothers. Several reports in adults have described hepatotoxicity associated with cocaine abuse. 8 However, no current information is available as to whether intrauterine exposure to cocaine or its metabolites affects the fetal liver. We hypothesized that isolated GGT elevations in the newborn may result from in utero exposure to maternally ingested GGT-inducing drugs, which may include cocaine -an illicit drug that has reached epidemic proportions in our community.
The aims of this study were to examine the level of GGT in the umbilical cord blood of a random population of normal newborns to establish a reference range, and to assess the influence that a number of perinatal variables (including epidemiological factors and cocaine exposure) have on cord blood GGT. Maternal serum was also examined to assess whether an elevated cord blood GGT value may be maternally derived and whether cocaine ingestion influenced maternal GGT activity.
METHODS

Data Collection
Over a 7-week period, cord blood was obtained from a random cohort of liveborn infants at the University of Chicago Hospitals.
OBJECTIVE:
The serum activity of the hepatic enzyme gamma -glutamyl transferase ( GGT ) is elevated in the newborn relative to older age groups. Few reports to date have studied the influence of perinatal factors on neonatal serum GGT and no study has assessed the influence of maternal drug ingestion.
STUDY DESIGN:
Cord blood was randomly collected from 234 liveborn infants and correlated with a range of maternal and fetal perinatal variables to assess influences on cord blood GGT.
RESULTS:
Our study showed that the range of cord blood GGT activity in 234 randomly selected term newborns was 22 to 556 IU / l. In a subgroup of 75 newborns, GGT activity was independently influenced by only two of the variables studied -cocaine exposure and fetal gender ( p = 0.009, r = 0.39 ). Females had a lower GGT than males ( 95 ± 66 vs 130 ± 90 IU / l, p < 0.001 ) while GGT activity in cocaine -exposed newborns was lower than in cocaine -nonexposed newborns ( 96 ± 48 vs 142 ± 109, p < 0.01 ). Birth weight, race, gestational age, and maternal serum GGT were not found to significantly influence cord blood GGT activity. Maternal GGT was uniformly normal and was not affected by any of the variables tested.
CONCLUSION:
Our findings demonstrate that the reference range for cord blood GGT activity is wide and appears to be influenced by fetal gender and cocaine exposure. 
Original Article
Infants over 36 weeks' gestation were eligible for enrolment in the study. We excluded infants with birth weights <2000 g and infants requiring intensive resuscitation and care. Maternal historical data were taken with particular attention to factors that may affect maternal GGT or high-risk behavior associated with illicit drug use and included: history of systemic illness, use of medications associated with GGT induction (e.g., antiepileptics, warfarin, phenobarbital), and substance abuse. Neonatal data included: gender, race, birth weight, gestational age, and Apgar scores. Cord blood was collected for GGT analysis in all infants in order to establish a normal GGT reference range for our population. In a randomly selected subpopulation, meconium was collected for analysis of cocaine and cocaine metabolites. 9 Urine samples were collected, when clinically indicated, from mothers and infants for suspicion of illicit drug use. This study was approved by the University of Chicago Hospitals Institutional Review Board.
Serum GGT
Umbilical cord blood and maternal blood samples were collected at the time of delivery. GGT activity was measured using the standard modified kinetic photometric assay based on the procedure described by Szasz.
10
Urine Drug Assays Maternal or newborn urine was collected within 24 to 48 hours of delivery for drug assay. Urine samples were analyzed by the enzymemediated immunoassay technique (EMIT dau cocaine metabolite assay; Syva Co., Palo Alto, CA) for cocaine and benzoylecognine. Separate immunoassays were used to test for opiates, benzodiazepines, and phencyclidine. Thin-layer chromatography was employed to test for antidepressants, phenothiazines, narcotic analgesics, and amphetamines.
Meconium Assay
Meconium samples were analyzed for cocaine and its metabolites with high-performance liquid chromatography (HPLC), as described by Browne et al. 9 Positive results were confirmed with gas chromatography mass spectrophotometry. 9 
Data Analysis
Ordinal data comparing cocaine-exposed and cocaine-nonexposed groups were analyzed using the unpaired Student's t-test and reported as mean±SD. Proportional data comparing the two exposure groups were analyzed by -squared analysis. Significance was considered at the p<0.05 levels.
RESULTS
Perinatal Variables
Of the 234 infants studied, females comprised 50.9% of the population. Birth weight and gestational age for each of the gender were similar. Mean birth weights were: males, 3079±592 g; females, 3140±642 g. Mean gestational ages were: males, 38.9±1.8 weeks; females, 37.8±2.9 weeks. Of subjects enrolled, 81% was AfricanAmerican, 9.5% Caucasian, 6.6% Hispanic, and 2.9% Asian with equal distribution of females and males in each subgroup. No use of warfarin, phenobarbital, or antiepileptics was detected in the maternal population studied.
Drug Testing
Of the 75 subjects with meconium analysis available, maternal cocaine use was identified via history, urine, or meconium analysis in 20 subjects (20/75=27%). Seventeen cases were identified through positivity in only one test (meconium n=13, newborn urine n=3, history n=1). In two cases, two methods of cocaine identification were positive (meconium and infant urine n=1, meconium and history n=1). In one case, cocaine testing was positive using all four methods. Other illicit drugs identified using urine testing were uncommon, representing less than 2% of the total population (barbiturates n=3, opiates n=2).
Cord Blood GGT Activity
The range of cord blood GGT activity for the entire newborn population studied was 22 to 556 IU/l, with mean of 113 IU/l (see Figure 1 ).
Variables Influencing Cord Blood GGT Activity
In a model that was controlled for birth weight, gestational age, race, and cocaine exposure, regression analysis demonstrated that cord blood GGT activity was independently influenced by cocaine exposure and gender. Univariate comparison of cord blood GGT activity based on gender demonstrated that females had a lower GGT than males (95±66 vs 130±90 IU/L, p<0.001), and cord blood GGT activity in cocaine-exposed fetuses was lower than in cocainenonexposed fetuses (96±48 vs 142±110, p<0.01). Gestational age, race, birth weight, and maternal GGT did not influence cord Figure 1 . This scattergram shows distribution of frequencies of cord blood GGT activities in 234 neonates included in the study.
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Determinants of Cord Blood GGT blood GGT activity. The relatively uncommon exposure to other illicit substances precluded identification of their possible role in cord blood GGT.
Maternal GGT Activity
The range of maternal GGT activities was 5 to 136 IU/l (mean 20±22 IU/l). Using a similar regression model, it was determined that maternal GGT activity was not influenced by any studied variable, including cocaine ingestion, fetal gender, gestational age, sex, race, birth weight, or cord blood GGT.
DISCUSSION
Our findings show that cord blood GGT activity is influenced by gender, with lower GGT activities in female infants, and that exogenous influences, such as maternal cocaine ingestion, can lower the activity of cord blood GGT compared to nonexposed neonates. In contrast, maternal serum GGT activity appears to be unaffected by cocaine ingestion. Xenobiotics can clearly affect serum GGT activity. Our study is the first to our knowledge to address the confounding factor of possible maternal drug ingestion as an influence on cord blood GGT activity. The original premise of this study was that incipient cocaine use may be responsible for raised GGT in newborns born to cocaine-using mothers. Unexpectedly, GGT was lower in cocaine-exposed newborns compared to nonexposed newborns. Cocaine is metabolized by plasma pseudocholinesterase, hepatic esterase, and the microsomal P450 metabolic pathway to norcocaine, benzoylecognine, ecgonine, and ecgonine methyl ester. The effect of cocaine on the adult liver is still being investigated, but cocaine-induced hepatotoxicity is a welldescribed phenomenon. 8 Although the P450 enzyme pathway only accounts for a minority of the drug's metabolism ( <10%), there is good evidence that this system is most likely to be responsible for the toxic effects of cocaine on the adult human liver. 11 Since drugs, such as phenobarbital that induces P450, are associated with an elevated serum GGT activity, one might expect nonhepatotoxic cocaine exposure to increase GGT activity.
In our study, maternal serum GGT was surprisingly unaffected by cocaine exposure, and contrary to our expectations, fetal serum GGT activity was actually decreased in the cocaine-exposed population. Since no attempt was made to assess the quantity, duration, or pattern of use of cocaine ingested, we cannot exclude the possibility that maternal exposure was too low to impact maternal serum GGT activity.
Several explanations are possible for the observed decrease in cord blood GGT activity in response to in utero cocaine exposure. Firstly, the fetus may metabolize cocaine through different metabolic pathways to those identified in the adult. Secondly, the immature fetal liver may be more susceptible to the effect of drug exposure than the mature adult liver. Thirdly, the source of serum GGT activity may be different in the fetus compared to the adult. The GGT activity measured in cord blood compared to maternal serum GGT may reflect a different subcellular origin or isoenzyme, and thus, cord blood GGT may be controlled by different endogenous and exogenous factors compared to the adult. Alternatively, the induction of liver enzymes over time following in utero drug exposure may have accounted for a relative fall in GGT by the time of birth. It should be noted that these infants were most likely exposed to multiple substances in utero, not just cocaine, and thus, other drugs may have played a role in liver enzyme levels. We presume cord blood GGT to be fetal in origin since maternal serum GGT activity is significantly lower than in the fetus at the time of delivery regardless of cocaine exposure status.
Our data also demonstrate that gender has a significant impact on the value of serum fetal GGT at the time of birth. We postulate that the fetal female hormonal environment impacts on the GGT response to other perinatal factors. This is supported by a report that GGT activity was increased less frequently and to a lesser degree in women who developed viral hepatitis during the latter half of pregnancy or while taking oral contraceptives. 12 This suggests that the extent of rise of serum GGT activity in response to such stimulus as hepatic injury or perinatal factors present at birth may be depressed by female hormones. The fetus is exposed to a high concentration of circulating estrogen, which may repress the natural rise in GGT in late gestation. It could be speculated that the inhibitory effects of estrogen are partially neutralized by male hormones, thus causing a greater cord blood GGT in male infants.
In conclusion, the reference range for human cord blood GGT is wide. The mean cord blood GGT activity is markedly higher than for older children and adults. Cord blood GGT activity in the normal infant is between 20 and 360 IU/l, but may be as high as 556 IU/l. Cord blood GGT activity is influenced by gender and exogenous influences, such as maternal cocaine ingestion, but there are likely as yet unidentified factors that influence the perinatal rise in serum GGT activity. This study helps to establish clear norms for measuring liver function in neonates, which will become increasingly important as the epidemic of hepatitis C infection continues to spread in this high-risk obstetric population.
